Clinical photocoagulation with the organic dye laser. A preliminary communication
F. A. L'Esperance Jr
Clinical research utilizing the yellow, orange, and red wavelengths of the
liquid organic dye laser has demonstrated that this laser may be
successfully used for photocoagulation of certain ophthalmic defects. The
advantage of the dye laser as a photocoagulation source is its capability
to produce monochromatic wavelengths at relatively high output powers
through a large range of the visible spectrum. Therefore, a target tissue
can be coagulated with minimal transmittal of laser energy through the
ocular media, by the selection of a wavelength that would be most highly
absorbed by that tissue. The dye laser, as a system that permits
transspectral photocoagulation, should prove valuable in the treatment of
ocular disease.
